Pharmacologic modulation of the whealing response to histamine in human skin: identification of doxepin as a potent in vivo inhibitor.
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D002744:Chlorpheniramine / Q000494:pharmacology; D004306:Dose-Response Relationship, Immunologic; D004311:Double-Blind Method; D004316:Doxepin / Q000494:pharmacology*; D006632:Histamine / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006801:Humans; D010919:Placebos; D012882:Skin Tests
D000929:Antidepressive Agents, Tricyclic; D006634:Histamine H1 Antagonists; D010919:Placebos; D004316:Doxepin; D002744:Chlorpheniramine; D006632:Histamine